RARE News
Ultragenyx Pharmaceutical Inc.
$15.13
+$0.23(+1.54%)
33
Overall
40
Value
10
Tech
50
Quality
Market Cap
$1.47B
Volume
501.49K
52W Range
$12.73 - $39.89
Target Price
$26.20
RARE news: the latest Ultragenyx Pharmaceutical Inc. headlines, press releases and market updates, newest first.
Latest RARE News
- Ultragenyx Pharmaceutical (RARE) Receives a New Rating from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Ultragenyx Pharmaceutical (RARE) Receives a Hold from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Ultragenyx Launches 10-Year Gene Therapy Monitoring Program for MPS IIIATipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
- Analysts Offer Insights on Healthcare Companies: Helus Pharma (HELP), Ultragenyx Pharmaceutical (RARE) and Novavax (NVAX)TipRanks Newsroom · Sep 21, 2026
- Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)TipRanks Newsroom · Sep 21, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $15.13 | +1.5% | 501.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW